Effectiveness of high‐dose transvaginal progesterone supplementation for women who are undergoing a frozen‐thawed embryo transfer
Open Access
- 11 March 2018
- journal article
- research article
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 17 (3) , 242-248
Abstract
Purpose: To evaluate the effectiveness of high‐dose progesterone supplementation for women who are undergoing a frozen‐thawed embryo transfer (FET).Methods: Among the 2010 FET cycles that were included in the present study, 1188 were 1200 mg/d of vaginal progesterone, while 822 were 900 mg/d. The dose of progesterone that was used was decided by the treatment period and additional progesterone supplementation was used when the serum progesterone levels were <9 ng/mL on luteal day 5.Results: The clinical pregnancy rate was higher in the 1200 mg group than in the 900 mg group. The mean serum progesterone level on luteal day 5 in the 1200 mg and 900 mg groups was 12.6 ng/mL and 13.4 ng/mL, respectively. The rate of additional progesterone supplementation was higher in the 1200 mg group. A logistic regression analysis identified a younger age (≤37 years) and the use of 1200 mg progesterone as independent predictive factors for the clinical pregnancy outcome. The analysis of the infant outcomes revealed no significant difference in the distribution of birth ages and weights.Conclusion: High‐dose transvaginal progesterone of 1200 mg/d as luteal support contributed to good pregnancy outcomes.Keywords
This publication has 27 references indexed in Scilit:
- Luteal-phase support in assisted reproduction treatment: real-life practices reported worldwide by an updated website-based surveyReproductive BioMedicine Online, 2014
- Endometrin as luteal phase support in assisted reproductionFertility and Sterility, 2013
- A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesteroneFertility and Sterility, 2009
- Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of a prospective randomized trialFertility and Sterility, 2008
- Vaginal gel versus intramuscular progesterone for luteal phase supplementation: a prospective randomized trialReproductive BioMedicine Online, 2008
- Luteal phase support in infertility treatment: a meta-analysis of the randomized trialsHuman Reproduction, 2002
- Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal womenFertility and Sterility, 2000
- Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administrationHuman Reproduction, 1999
- Oral versus intramuscular progesterone for in vitro fertilization: a prospective randomized studyFertility and Sterility, 1999
- The role of luteal phase support in infertility treatment: a meta-analysis of randomized trialsFertility and Sterility, 1994